Testosterone enhancement of exposure therapy in social anxiety disorder
Completed
- Conditions
- Social anxiety disorderSpeach anxietyExposure therapySociale angststoornisSpreekangstExposure behandeling
- Registration Number
- NL-OMON20251
- Lead Sponsor
- Prof. dr. Karin Roelofs-Radboud University Nijmegen, Behavioural Science Institute (BSI) & Donders Institute for Brain, Cognition and Behaviour, Radboud University Nijmegen, Postbus 9101, 6500 HB Nijmegen-Leiden University, Faculty of Social and BehaviouralSciences, Institute of PsychologyWassenaarseweg 52, 2333 AK LeidenK.roelofs@donders.ru.nl
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 52
Inclusion Criteria
Woman, 18-45 years old
- Social Anxiety Disorder (SAD) as established with a structured interview (MINI), and with speech anxiety as primary fear
Exclusion Criteria
- Prior non response to exposure therapy (i.c. speech exposure) for SAD symptoms, as defined by the patient’s report of receiving specific and regular exposure assignments as part of previous therapy.
- Entry of patients with other mood or anxiety disorders will be permitted in order to increase accrual of a clinically relevant sample; however in cases where SAD is not judged to be the predominant disorder, participants will not be eligible.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Our main outcome is subjective anxiety, as assessed by Subjective Units of Distress (SUDs). participants will provide fear ratings (ranging from 0; no fear to 100 most anxiety imaginable) prior and during both exposure sessions.
- Secondary Outcome Measures
Name Time Method